Quick Answer
Guardant Health, Inc. reported Cash and Equivalents of $378.20 million for fiscal year 2025.
Guardant Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $378.20M | -28.0% |
| 2024 | $525.54M | -53.6% |
| 2023 | $1.13B | +700.3% |
| 2022 | $141.65M | -71.2% |
| 2021 | $492.20M | -40.9% |
| 2020 | $832.98M | +481.6% |
| 2019 | $143.23M | +1.9% |
| 2018 | $140.54M | +94.4% |
| 2017 | $72.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $580.01M | -0.9% | -7.8% |
| June 30, 2025 | $629.14M | -32.6% | -9.9% |
| March 31, 2025 | $698.57M | -32.1% | +32.9% |
| December 31, 2024 | $525.54M | — | -10.2% |
| September 30, 2024 | $585.02M | +27.9% | -37.3% |
| June 30, 2024 | $933.69M | +244.4% | -9.3% |
| March 31, 2024 | $1.03B | +360.1% | +125.0% |
| September 30, 2023 | $457.34M | +188.9% | +68.7% |
- Guardant Health, Inc. showed a decrease of -28.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, Guardant Health, Inc.’s cash and equivalents has grown by 423.2% (from $72.28 million to $378.20 million).
- The most recent figure is from Guardant Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: